Technical requirements for the licensing of pseudorabies (Aujeszky's disease) vaccines in the European Union

Advances in Veterinary Medicine

Volumn 41, Issue C, 1999, Pages 615-626

  Vannier, P ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; PSEUDORABIES VACCINE; VIRUS VACCINE;

ANIMAL; ARTICLE; EUROPEAN UNION; IMMUNOLOGY; LICENSING; PASSIVE IMMUNIZATION; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; QUALITY CONTROL; STANDARD; SWINE; SWINE DISEASE;

ANIMALS; EUROPEAN UNION; HERPESVIRUS 1, SUID; IMMUNIZATION, PASSIVE; LICENSURE, PHARMACY; PSEUDORABIES; PSEUDORABIES VACCINES; QUALITY CONTROL; SWINE; SWINE DISEASES; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0032614927     PISSN: 1093975X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3519(99)80047-0     Document Type: Chapter

References (17)

1. Andries K., Pensaert M.B., and Vandeputte J. Effect of experimental infection with pseudorabies (Aujeszky's Disease) virus on pigs with maternal immunity from vaccinated sows. Am. J. Vet. Res. 39 8 (1978) 1282-1285
2. de Leeuw P.W., and Van Oirschot J.T. Vaccines against Aujeszky's disease: Evaluation of their efficacy under standardized laboratory conditions. Vet. Q. 7 (1985) 780-786
3. Hall W., Molitor T.W., Joo H.S., and Pijoan C. Comparison of protective immunity and inflammatory responses of pigs following immunization with different Actinobacillus pleuropneumoniae preparations with and without adjuvants. Vet. Immunol. Immunopathol. 22 (1989) 175-186
4. Henderson L.M., Randall L.L., David A.J., and Stutz D.R. Recombination of pseudorabies virus vaccine strains in swine. Am. J. Vet. Res. 52 6 (1991) 820-825
5. Kit, S. (1989) Safety and efficacy of genetically engineered Aujeszky's disease vaccines. In "Vaccination and Control of Aujeszky's Disease," (J. T. Van Oirschot, ed.), pp. 45-55.
6. McFerran J.B., and Dow C. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus. Res. Vet. Sci. 19 (1975) 17-22
7. Mengeling W.L. Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus. Arch. Virol. 120 (1991) 57-70
8. Pensaert M.B., de Smet K., and de Waele K. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different Glycoprotein-Deleted Aujeszky's disease vaccines. Vet. Microbiol. 22 (1990) 107-117
9. Stellmann C., Vannier P., Chappuis G., Brun A., Dauvergne M., Fargeaud D., Bugaud M., and Colson X. The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J. Biol. Stand. 17 (1989) 17-27
10. Toma B. Obtention et caracterisation d'une souche thermosensible de virus de la maladie d'Aujeszky (souche ALFORT 26). Recl. Med. Vet. 155 2 (1979) 131-137
11. Toma B., Brun A., Chappuis G., and Terre J. Propriétés biologiques d'une souche thermosensible (ALFORT 26) de virus de la maladie d'Aujeszky. Recl. Med. Vet. 155 3 (1979) 245-252
12. Vannier P. Immunisation de porcs charcutiers contre la maladie d'Aujeszky avec deux vaccins à adjuvants huileux. Etude des réactions locales. Recl. Med. Vet. 162 1 (1986) 37-44
13. Vannier P., Tillon J.P., Toma B., Delagneau J.F., Loquerie R., and Prunet P. Protection conférée au porc par un nouveau vaccin huileux à virus inactivé contre la maladie d'Aujeszky. Conséquences pratiques. J. Rech. Porc. Fr. (1976) 281-290
14. Vannier P., Hutet E., Bourgueil E., and Cariolet R. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's diseases vaccines. Vet. Microbiol. 29 (1991) 213-223
15. Van Oirschot J.T., and Gielkens A.L.J. Intranasal vaccination of pigs against pseudorabies: Absence of vaccinal virus latency and failure to prevent latency of virulent virus. Am. J. Vet. Res. 45 10 (1984) 2099-2103
16. Van Oirschot J.T., Terpstra C., Moormann R.J.M., Berns A.J.M., and Gielkens A.L.J. Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein I. Vet. Rec. 127 (1990) 443-446
17. Visser, N., and Lütticken, D. (1989). Experiences with a gl-/TK- modified live pseudorabies virus vaccine: Strain Begonia. In "Vaccination and Control of Aujeszky's Disease" (J. T. Van Oirschot, ed.), 37-44.